Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study

MLA

Junyan Wu, et al. “Immune Checkpoint Inhibitors Increase the Risk of Kidney Transplant Rejection: A Real-World Pharmacovigilance Study.” Expert Opinion on Drug Safety, Aug. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....17c78711b53741d9e77eba90f29678d8&authtype=sso&custid=ns315887.

APA

Junyan Wu, Jianxiang Huang, Jianhong Zhu, Zhichao He, Mengting Chen, Siyuan Gao, Dan Liang, Xiaoxia Yu, & Chengyu Lu. (2022). Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study. Expert Opinion on Drug Safety.

Chicago

Junyan Wu, Jianxiang Huang, Jianhong Zhu, Zhichao He, Mengting Chen, Siyuan Gao, Dan Liang, Xiaoxia Yu, and Chengyu Lu. 2022. “Immune Checkpoint Inhibitors Increase the Risk of Kidney Transplant Rejection: A Real-World Pharmacovigilance Study.” Expert Opinion on Drug Safety, August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....17c78711b53741d9e77eba90f29678d8&authtype=sso&custid=ns315887.